These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23047930)

  • 1. Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance.
    Gorden P; Zadeh ES; Cochran E; Brown RJ
    Endocr Pract; 2012; 18(5):763-71. PubMed ID: 23047930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome.
    Lungu AO; Zadeh ES; Goodling A; Cochran E; Gorden P
    J Clin Endocrinol Metab; 2012 Feb; 97(2):563-7. PubMed ID: 22090274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
    Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
    J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.
    Musso C; Cochran E; Moran SA; Skarulis MC; Oral EA; Taylor S; Gorden P
    Medicine (Baltimore); 2004 Jul; 83(4):209-222. PubMed ID: 15232309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome: insulin resistance.
    Mikhail N
    Curr Hypertens Rep; 2009 Apr; 11(2):156-8. PubMed ID: 19278606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodystrophy: metabolic insights from a rare disorder.
    Huang-Doran I; Sleigh A; Rochford JJ; O'Rahilly S; Savage DB
    J Endocrinol; 2010 Dec; 207(3):245-55. PubMed ID: 20870709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical approach to severe insulin resistance.
    Savage DB; Semple RK; Chatterjee VKK; Wales JKH; Ross RJM; O'Rahilly S
    Endocr Dev; 2007; 11():122-132. PubMed ID: 17986832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.
    Kushchayeva YS; Kushchayev SV; Startzell M; Cochran E; Auh S; Dai Y; Lightbourne M; Skarulis M; Brown RJ
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2216-2228. PubMed ID: 30657911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte Dynamics and Reversible Metabolic Syndrome in Mice with an Inducible Adipocyte-Specific Deletion of the Insulin Receptor.
    Sakaguchi M; Fujisaka S; Cai W; Winnay JN; Konishi M; O'Neill BT; Li M; García-Martín R; Takahashi H; Hu J; Kulkarni RN; Kahn CR
    Cell Metab; 2017 Feb; 25(2):448-462. PubMed ID: 28065828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time.
    Kalra SP; Kalra PS
    EXS; 2006; (95):157-69. PubMed ID: 16383005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.
    Rizvi AA; Stoian AP; Rizzo M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children.
    Madeira IR; Bordallo MA; Carvalho CN; Gazolla FM; de Souza FM; de Matos HJ; Borges MA
    J Pediatr Endocrinol Metab; 2011; 24(5-6):289-95. PubMed ID: 21823525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid overload and overflow: metabolic trauma and the metabolic syndrome.
    Unger RH
    Trends Endocrinol Metab; 2003 Nov; 14(9):398-403. PubMed ID: 14580758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipodystrophy: Syndrome of severe insulin resistance.
    Bindlish S; Presswala LS; Schwartz F
    Postgrad Med; 2015 Jun; 127(5):511-6. PubMed ID: 25690482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.
    Wong SP; Huda M; English P; Bargiota A; Wilding JP; Johnson A; Corrall R; Pinkney JH
    Diabetologia; 2005 Dec; 48(12):2641-9. PubMed ID: 16320084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene.
    Iwanishi M; Kusakabe T; Azuma C; Tezuka Y; Yamamoto Y; Ito-Kobayashi J; Washiyama M; Morimoto M; Ebihara K
    Diabetes Res Clin Pract; 2019 Jun; 152():79-87. PubMed ID: 31102683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity.
    Caceres M; Teran CG; Rodriguez S; Medina M
    BMC Pediatr; 2008 Aug; 8():31. PubMed ID: 18700035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue and metabolic syndrome: too much, too little or neither.
    Grundy SM
    Eur J Clin Invest; 2015 Nov; 45(11):1209-17. PubMed ID: 26291691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone deficiency, insulin resistance and the metabolic syndrome.
    Zitzmann M
    Nat Rev Endocrinol; 2009 Dec; 5(12):673-81. PubMed ID: 19859074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity.
    Lee HJ; Jang HB; Kim WH; Park KJ; Kim KY; Park SI; Lee HJ
    Sci Rep; 2019 Sep; 9(1):13610. PubMed ID: 31541119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.